A comparison of subgroup analyses in grant applications and publications

American Journal of Epidemiology

Volumn 174, Issue 2, 2011, Pages 219-225

  Boonacker, Chantal W B ^a   Hoes, Arno W ^a   Van Liere Visser, Karen ^b   Schilder, Anne G M ^a,c   Rovers, Maroeska M ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Netherlands Organisation for Health Research and Development   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

analysis; epidemiologic methods; publications; research; statistics

Indexed keywords

COMPARATIVE STUDY; EPIDEMIOLOGY; RESEARCH AND DEVELOPMENT; RESEARCH WORK; STATISTICAL ANALYSIS; THEORETICAL STUDY;

ARTICLE; HEALTH CARE ORGANIZATION; MEDICAL RESEARCH; NETHERLANDS; POST HOC ANALYSIS; PUBLICATION;

BIOMEDICAL RESEARCH; FEMALE; HUMANS; MALE; PUBLICATIONS; RESEARCH SUPPORT AS TOPIC;

EID: 79960511099     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr075     Document Type: Article

References (30)

1. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ. 1995;310(6990): 1315-1318.
2. Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet. 1999;353(9154):743-746. (Pubitemid 29103819)
3. Rothwell PM. Medical academia is failing patients and clinicians. BMJ. 2006;332(7546):863-864. (Pubitemid 44365575)
4. Assmann SF, Pocock SJ, Enos LE, et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355(9209):1064-1069. (Pubitemid 30162810)
5. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116(1):78-84.
6. Brookes ST, Whitely E, Egger M, et al. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57(3):229-236. (Pubitemid 38456874)
7. Pocock SJ, Assmann SE, Enos LE, et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002; 21(19):2917-2930.
8. Aulakh AK, Anand SS. Sex and gender subgroup analyses of randomized trials. Womens Health Issues. 2007;17(6): 342-350.
9. Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know: subgroup analyses. J Thorac Oncol. 2010;5(5):741-746.
10. Stallones RA. The use and abuse of subgroup analysis in epidemiological research. Prev Med. 1987;16(2):183-194. (Pubitemid 17067794)
11. Hernández AV, Boersma E, Murray GD, et al. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Am Heart J. 2006;151(2):257-264. (Pubitemid 43148981)
12. Parker AB, Naylor CD. Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials. Am Heart J. 2000;139(6):952-961. (Pubitemid 30390322)
13. Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365(9454):176-186. (Pubitemid 40091809)
14. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266(1):93-98.
15. Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189-2194.
16. FernandezGarcia Y, Garcia E, Nguyen H, Duan N, et al. Assessing heterogeneity of treatment effects: are authors misinterpreting their results? Health Serv Res. 2010;45(1): 283-301.
17. Bhandari M, Devereaux PJ, Li P, et al. Misuse of baseline comparison tests and subgroup analyses in surgical trials. Clin Orthop Relat Res. 2006;447:247-251. (Pubitemid 44324921)
18. Gabler NB, Duan N, Liao D, et al. Dealing with heterogeneity of treatment effects: is the literature up to the challenge? [electronic article]. Trials. 2009;10:43.
19. Hernández AV, Steyerberg EW, Taylor GS, et al. Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: a systematic review. Neurosurgery. 2005;57(6):1244-1253. (Pubitemid 41827419)
20. Knol MJ, Egger M, Scott P, et al. When one depends on the other: reporting of interaction in case-control and cohort studies. Epidemiology. 2009;20(2):161-166.
21. Moreira ED Jr, Stein Z, Susser E. Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals. Braz J Med Biol Res. 2001;34(11):1441-1446. (Pubitemid 34036847)
22. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice [electronic artcle]. BMJ. 2004;329(7471):883.
23. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8): 663-694. (Pubitemid 32322245)
24. Brookes ST, Whitley E, Peters TJ, et al. Subgroup analyses in randomised controlled trials: quantifying the risks of falsepositives and false-negatives. Health Technol Assess. 2001; 5(33):1-56.
25. Bulpitt CJ. Subgroup analysis. Lancet. 1988;2(8601): 31-34.
26. Fayers PM, King MT. How to guarantee finding a statistically significant difference: the use and abuse of subgroup analyses. Qual Life Res. 2009;18(5):527-530.
27. Grouin JM, Coste M, Lewis J. Subgroup analyses in randomized clinical trials: statistical and regulatory issues. J Biopharm Stat. 2005;15(5):869-882. (Pubitemid 41022996)
28. Hasford J, Bramlage P, Koch G, et al. Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. J Clin Epidemiol. 2010;63(12):1298-1304.
29. Sun X, Briel M, Walter SD, et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:850-854.
30. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163-W194. (Pubitemid 351664503)